No Data
Research reports dig deep into the third quarter, with imeik technology development maintaining good profitability and maintaining a "buy" rating.
Gelonghui November 11th | Changjiang Securities research report pointed out that it is expected that imeik technology development (300896.SZ) will experience a slowdown in revenue growth in 2024Q3 due to end demand, but overall still maintains good profitability. Overall, the company has kept the relative stability of the operating profit margin, with a quarterly growth rate of about 2% in net income attributable to the parent, slightly faster than the revenue growth rate. Currently, the company's Hi series products have established a good consumer mind share, and are expected to continue to benefit from the ongoing trend of light medical beauty consumption and compliant operation trends; at the same time, the joint application of Rubai Angel and Reway Angel is expected to continue to solidify the high-end price range, while various future potential benefits
imeik technology development (300896): Income growth slows down, maintaining good profitability in the third quarter.
The company disclosed its third quarter report for 2024, with a revenue of 0.719 billion yuan in the third quarter alone, an increase of 1.1% year-on-year, and a net income attributable to shareholders of 0.465 billion yuan, an increase of 2.13% year-on-year. Comments on the event 2024Q3.
imeik technology development (300896): Q3 24 profit quality improvement Pay attention to the catalytic effect of consumption recovery on performance.
Event: The company released the Q3 24 performance review, with steady growth in revenue and profit for the first three quarters. In the first three quarters, the company achieved revenue of 2.38 billion yuan (+9.5%) and a net income attributable to the parent company of 1.59 billion yuan (+11.8%). By quarter.
imeik technology development (300896): Decreased growth pressure due to slowing down of high-margin products, looking forward to new product layout.
Investment Highlights 24Q3: Quarterly revenue growth slows down, non-GAAP profits are under pressure. 24Q1-Q3: Revenue of 2.38 billion yuan (+9%, same below); net profit attributable to equity holders of 1.59 billion yuan (+12%); non-GAAP net income
imeik technology development (300896): Innovative and high-end deep layout, looking forward to the outstanding performance of new products.
Event: In the first three quarters of 2024, the company achieved revenue of 2.376 billion yuan, a year-on-year increase of +9.46%, net income attributable to shareholders of 1.586 billion yuan, a year-on-year increase of +11.79%, and non-recurring net income attributable to shareholders of 1.53 billion yuan, year-on-year
imeik technology development (300896): Q3 growth rate slows down, reserve pipeline steadily advances to ensure future growth.
The company achieved revenue of 2.376 billion in the first three quarters, a year-on-year increase of 9.5%, and achieved a net income attributable to shareholders of 1.59 billion, a year-on-year increase of 11.8%. Looking at Q3 alone, revenue and net income attributable to shareholders increased by 1% and 2% respectively.
No Data
No Data